Litcius/Paper detail

Electrochemical Impedance-Based Biosensors for the Label-Free Detection of the Nucleocapsid Protein from SARS-CoV-2

Hana Cho, Suhyun Shim, Won Woo Cho, Sungbo Cho, Hanseung Baek, Sang-Myung Lee, Dong‐Sik Shin

2022ACS Sensors39 citationsDOI

Abstract

Diagnosis of coronavirus disease (COVID-19) is important because of the emergence and global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Real-time polymerase chain reaction (PCR) is widely used to diagnose COVID-19, but it is time-consuming and requires sending samples to test centers. Thus, the need to detect antigens for rapid on-site diagnosis rather than PCR is increasing. We quantified the nucleocapsid (N) protein in SARS-CoV-2 using an electro-immunosorbent assay (El-ISA) and a multichannel impedance analyzer with a 96-interdigitated microelectrode sensor (ToAD). The El-ISA measures impedance signals from residual detection antibodies after sandwich assays and thus offers highly specific, label-free detection of the N protein with low cross-reactivity. The ToAD sensor enables the real-time electrochemical detection of multiple samples in conventional 96-well plates. The limit of detection for the N protein was 0.1 ng/mL with a detection range up to 10 ng/mL. This system did not detect signals for the S protein. While this study focused on detecting the N protein in SARS-CoV-2, our system can also be widely applicable to detecting various biomolecules involved in antigen-antibody interactions.

Topics & Concepts

BiosensorSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakElectrical impedanceNanotechnologyCoronavirusSars virusElectrochemistryMaterials scienceVirologyChemistryMedicineElectrodeInfectious disease (medical specialty)EngineeringPathologyElectrical engineeringPhysical chemistryOutbreakDiseaseSARS-CoV-2 detection and testingAdvanced biosensing and bioanalysis techniquesBiosensors and Analytical Detection